Biliary cancer (Cholangiocarcinoma) remains a rare but important cause of cancer related mortality worldwide. Although surgical resection can be curative in some select cases, most patients present with advanced, incurable disease not suitable for surgery. Currently, these patients have a median survival of 1-2 years with palliative chemotherapy regimens.

ACME ABC is a prospective, multi-centre cohort study recruiting patients from moderate-to-high volume hepaticopancreaticobiliary cancer units in Australia with a target accrual of at least 50 patients.

Presenter

Dr Daniel Croagh
Monash Health

Session

Tuesday, 14 November

Session 3: Biliary Tract and Liver Cancer (Early)

Download materials

Download the full abstract

Download the study schema

Study schema

Click to expand

ACME ABC schema. Please contact us if you require a screen-readable version.